Related Experiment Video
Updated: Nov 21, 2025

10:11
Whole-Body Nanoparticle Aerosol Inhalation Exposures
Published on: May 7, 2013
16.1K
Environmentally Relevant Iron Oxide Nanoparticles Produce Limited Acute Pulmonary Effects in Rats at Realistic
Chang Guo1, Ralf J M Weber2, Alison Buckley1
1Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Harwell Campus, Didcot, Oxfordshire OX11 0RQ, UK.
International Journal of Molecular Sciences
|January 12, 2021
Summary
Inhaled iron oxide nanoparticles (FeOxNPs) did not cause toxicity in lung cells or rats, even at high doses. Multi-omics analyses revealed no adverse molecular changes, suggesting low risk from these environmental particles.
Area of Science:
- Environmental Science
- Toxicology
- Nanotechnology
Background:
- Iron oxide nanoparticles (FeOxNPs) are common in airborne particulate matter.
- Previous studies on FeOxNP toxicity yielded conflicting results.
- Existing research often lacks environmental relevance in particle characteristics.
Purpose of the Study:
- To assess the toxicity of environmentally relevant FeOxNPs.
- To investigate Fe3O4 and mixed FeOx forms due to preliminary cytotoxicity findings.
- To explore molecular responses using multi-omics in vitro and in vivo.
Main Methods:
- In vitro studies used human bronchial epithelial cells (BEAS-2B).
- In vivo studies involved Sprague-Dawley rats exposed via inhalation.
- Multi-omics analyses (transcriptomics, metabolomics) were performed at sub-cytotoxic concentrations.
Main Results:
- No clinical signs of toxicity were observed in rats.
- Bronchoalveolar lavage fluid (BALF) cell counts and LDH levels remained unchanged.
- No significant transcriptomic or metabolomic alterations indicating adverse effects were detected in lung or BEAS-2B cells.
Conclusions:
- Environmentally relevant FeOxNPs, including Fe3O4 and FeOx-mix, did not induce toxicity in vitro or in vivo.
- High-dose inhalation exposure did not elicit adverse clinical or molecular responses.
- The study suggests a low risk associated with exposure to these specific iron oxide nanoparticles.

